Oral Cancer : Pharmacology

Oral Cavity Cancer is associated with high incidence of loco-regional recurrences, which account for the majority of treatment failures post-surgery and radiotherapy. The time-course of relapse manifestation and metastasis are unpredictable. Relapsed OCC represents a major clinical challenge in part due to their aggressive and invasive behaviors. Chemotherapy remains the only option for advanced OCC whenever salvage surgery or re-irradiation is not feasible, but its efficacy is limited as a result of the drug resistance development. Alternatives to use of different permutations of standard cytotoxic drugs or combinations with modulators of drug resistance have led to incremental therapeutic benefits.

  • Clinical pharmacology
  • Biochemical pharmacology
  • Radiation biology
  • Molecular carcinogenesis

Related Conference of Oral Cancer : Pharmacology

October 16-18, 2017

25th Euro Congress and Expo on Dental & Oral Health

Budapest, Hungary
October 26-28, 2017

39th Asia-Pacific Dental and Oral Care Congress

Osaka, Japan
November 13-14, 2017

American World Dentistry

San Antonio, USA
February 26-28, 2018

21st Annual World Dental Summit

Paris, France
March 22-23, 2018

29th Annual American Dentistry Congress

New York, USA
April 02-03, 2018

World of Dentistry:
Current and Future Perspectives

Miami, Florida, USA
April 9-10, 2018

22nd International Conference on Dental Education

Amsterdam , Netherlands
July 23-25, 2018

32nd Asia Pacific Dental and Oral Health Congress

Melbourne, Australia
October 15-16, 2018

18th Annual Meeting on Oral Care & Oral Cancer

Las Vegas, USA
(10 Plenary Forums - 1 Event)
October 22-23, 2018

World Dental Implants and Orthodontics Congress

Osaka, Japan
October 22-23, 2018

Annual Congress on Endodontics and Prosthodontics

Osaka, Japan

Oral Cancer : Pharmacology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in